Application of Nano Drugs in Treatment of Leishmaniasis
<p><strong>Objective:</strong> Leishmaniasis is endemic in 88 countries with incidence rate of 1.5-2 million; the most common form of leishmaniasis is cutaneous leishmaniasis (CL) with 1.5 million new cases per year. Correct diagnosis and characterization of the particular parasite...
Na minha lista:
Principais autores: | Seyed Hossein Shahcheraghi (Autor), Jamshid Ayatollahi (Autor), Marzieh Lotfi (Autor), Ali Fattahi Bafghi (Autor), Seyed Hossein Khaleghinejad (Autor) |
---|---|
Formato: | Livro |
Publicado em: |
Global Journal of Infectious Diseases and Clinical Research - Peertechz Publications,
2016-08-19.
|
Assuntos: | |
Acesso em linha: | Connect to this object online. |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Registros relacionados
-
Epidemiological Study an Outbreak of Cutaneous Leishmaniasis in Five Endemic Foci, Yazd Province, March 2015-March 2016.
por: Mohammad Hassan Lotfi, et al.
Publicado em: (2017) -
Current Applications of Plant-Based Drug Delivery Nano Systems for Leishmaniasis Treatment
por: Darline B. dos Santos, et al.
Publicado em: (2022) -
Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (SinaAmpholeish) in Animal Model as a Candidate for Treatment of Cutaneous Leishmaniasis
por: Seyed Ebrahim Eskandari, et al.
Publicado em: (2018) -
Epidemiological Pattern of Cutaneous Leishmaniasis in the Province of Fars, Iran (Since 2010-2014)
por: Ali Fattahi Bafghi, et al.
Publicado em: (2016) -
Isolation and Molecular Identification of Leishmania spp. in Patients With Cutaneous Leishmaniasis in Golestan Province, Iran
por: Ali Fattahi Bafghi, et al.
Publicado em: (2019)